Literature DB >> 6765173

Control of HLA-A,B,C synthesis and expression in interferon-treated cells.

O R Burrone, C Milstein.   

Abstract

Cytofluorimetric analyses with monoclonal antibodies were used to follow the specific effect of highly purified human leucocyte interferon (IFN-alpha) on the expression of transplantation antigens (HLA)1 in Molt 4, a thymus leukaemia cell line. After a lag period of approximately 10 h the amount of HLA steadily increases to reach a maximum at day six of approximately 10 times its original. The effect is reversible and due to an increase in the rate of synthesis of HLA and beta 2m molecules as demonstrated by analysis of [35S]methionine incorporation into specific proteins after a 3-h pulse of Molt 4 cells treated with IFN-alpha for one or six days. A dramatic increase in the amount of mRNA that hybridised with a [32P]cDNA probe containing HLA sequences has also been demonstrated. Surface iodination of IFN-treated Molt 4 cells showed an increase in the iodinated HLA and beta 2m chains and in addition another, apparently unrelated, component with an apparent mol. wt. of 16 000. This component, which appears after incubations with IFN-alpha for longer than 1 h at 37 degrees C, was also detected in the B lymphoid cell lines RAJI and DAUDI.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6765173      PMCID: PMC553047          DOI: 10.1002/j.1460-2075.1982.tb01172.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  21 in total

1.  Identification of the cell multiplication inhibitory factors in interferon preparations as interferons.

Authors:  W E Stewart; I Gresser; M G Tovey; M Bandu; S Le Goff
Journal:  Nature       Date:  1976-07-22       Impact factor: 49.962

2.  Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized film.

Authors:  R A Laskey; A D Mills
Journal:  FEBS Lett       Date:  1977-10-15       Impact factor: 4.124

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  A monoclonal antibody for large-scale purification of human leukocyte interferon.

Authors:  D S Secher; D C Burke
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

5.  Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer.

Authors:  A K Sood; D Pereira; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

6.  The beta2-microglobulin gene is on chromosome 15 and not in the HL-A region.

Authors:  P N Goodfellow; E A Jones; V Van Heyningen; E Solomon; M Bobrow; V Miggiano; W F Bodmer
Journal:  Nature       Date:  1975-03-20       Impact factor: 49.962

7.  Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.

Authors:  A Adams; H Strander; K Cantell
Journal:  J Gen Virol       Date:  1975-08       Impact factor: 3.891

8.  Growth inhibition of human lymphoblastoid Daudi cells in vitro by interferon preparations.

Authors:  J Hilfenhaus; H Damm; H E Karges; K F Manthey
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Interferon enhances the amount of membrane-bound beta2-microglobulin and its release from human Burkitt cells.

Authors:  M Fellous; R Bono; F Hyafil; I Gresser
Journal:  Eur J Immunol       Date:  1981-06       Impact factor: 5.532

10.  Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.

Authors:  P Lindahl; I Gresser; P Leary; M Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

View more
  31 in total

1.  Analysis of HLA-ABC locus-specific transcription in normal tissues.

Authors:  Ana Belén García-Ruano; Rosa Méndez; José María Romero; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Immunogenetics       Date:  2010-09-15       Impact factor: 2.846

2.  An HLA-B regulatory element binds a factor immunologically related to the upstream stimulation factor.

Authors:  J Girdlestone
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

Review 3.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 4.  IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.

Authors:  M Hokland; P Basse; J Justesen; P Hokland
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

5.  Interferon alters the pattern of secreted proteins from Ehrlich ascites-tumour cells.

Authors:  S Tominaga; K Tominaga
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

6.  Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells.

Authors:  M McMahon; G R Stark; I M Kerr
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

7.  A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes.

Authors:  A Israël; A Kimura; M Kieran; O Yano; J Kanellopoulos; O Le Bail; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Molecular analysis of the bare lymphocyte syndrome.

Authors:  K E Sullivan; J D Stobo; B M Peterlin
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

9.  Identification of negative and positive regulatory elements associated with a class I major histocompatibility complex gene.

Authors:  R Ehrlich; J E Maguire; D S Singer
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Tumor necrosis factor alpha stimulates expression of adenovirus early region 3 proteins: implications for viral persistence.

Authors:  H Körner; U Fritzsche; H G Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.